Discovering the strength of immunometabolism in cancer therapy: Employing metabolic pathways to enhance immune responses
Cell Biochemistry and Function · 2024-03 · 42 (2)
DOI: 10.1002/cbf.3934 ↗At a glance
Übersichtsarbeit in Cell Biochemistry and Function, published online on 2024-01-28. Written by Huldani Huldani and 8 co-authors. Institution: Department of Physiology, Universitas Lambung Mangkurat, Banjarmasin, South Kalimantan, Indonesia. Major MEDLINE topics: Metabolic Networks and Pathways, Neoplasms. Cited 18 times so far (Crossref); 116 references. Funded by: King Khalid University.
Abstract (original language)
Immunometabolism, which studies cellular metabolism and immune cell function, is a possible cancer treatment. Metabolic pathways regulate immune cell activation, differentiation, and effector functions, crucial to tumor identification and elimination. Immune evasion and tumor growth can result from tumor microenvironment metabolic dysregulation. These metabolic pathways can boost antitumor immunity. This overview discusses immune cell metabolism, including glycolysis, oxidative phosphorylation, amino acid, and lipid metabolism. Amino acid and lipid metabolic manipulations may improve immune cell activity and antitumor immunity. Combination therapy using immunometabolism‐based strategies may enhance therapeutic efficacy. The complexity of the metabolic network, biomarker development, challenges, and future approaches are all covered, along with a summary of case studies demonstrating the effectiveness of immunometabolism‐based therapy. Metabolomics, stable isotope tracing, single‐cell analysis, and computational modeling are also reviewed for immunometabolism research. Personalized and combination treatments are considered. This review adds to immunometabolism expertise and sheds light on metabolic treatments' ability to boost cancer treatment immunological response. Also, in this review, we discussed the immune response in cancer treatment and altering metabolic pathways to increase the immune response against malignancies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Physiology, Universitas Lambung Mangkurat, Banjarmasin, South Kalimantan, Indonesia.
- Institute of Advance Bioinformatics, Bhopal, Madhya Pradesh, India.
- Department of Computer Engineering, King Khalid University, Al-Faraa, Asir-Abha, Saudi Arabia.
- Department of Medical Laboratory Sciences, Prince Sattam bin Abdulaziz University College of Applied Medical Sciences, Al-Kharj, Saudi Arabia.
- Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India.
- Department of Biology, College of Education For Pure Sciences, University of Anbar, Ramadi, Anbar, Iraq.
Funding
- King Khalid University
Cite
APA
Huldani, H., Malviya, J., Rodrigues, P., Hjazi, A., Deorari, M. M., Al-Hetty, H. R. A. K., Qasim, Q. A., Alasheqi, M. Q., & Ihsan, A. (2024). Discovering the strength of immunometabolism in cancer therapy: Employing metabolic pathways to enhance immune responses. Cell Biochemistry and Function, 42(2). https://doi.org/10.1002/cbf.3934
Vancouver
Huldani H, Malviya J, Rodrigues P, Hjazi A, Deorari MM, Al-Hetty HRAK, et al. Discovering the strength of immunometabolism in cancer therapy: Employing metabolic pathways to enhance immune responses. Cell Biochemistry and Function. 2024;42(2). doi:10.1002/cbf.3934
BibTeX
@article{Huldani2024,
author = {Huldani, Huldani and Malviya, Jitendra and Rodrigues, Paul and Hjazi, Ahmed and Deorari, Maha Medha and Al-Hetty, Hussein Riyadh Abdul Kareem and Qasim, Qutaiba A and Alasheqi, Mohammed Qasim and Ihsan, Ali},
title = {Discovering the strength of immunometabolism in cancer therapy: Employing metabolic pathways to enhance immune responses},
journal = {Cell Biochemistry and Function},
year = {2024},
volume = {42},
number = {2},
doi = {10.1002/cbf.3934}
}
EUVIMED